Atish Choudhury, MD PhD
@atishchoudhury.bsky.social
Medical Oncologist
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Views expressed herein are my own
https://scholar.google.com/citations?user=sJ4jYT0AAAAJ&hl=en
Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Views expressed herein are my own
https://scholar.google.com/citations?user=sJ4jYT0AAAAJ&hl=en
Thank you to NCCN, Sumitomo Pharma, Pfizer Oncology, and Bayer Oncology for supporting CLEARED (Comeback from Long CoursE ADT with RElugolix and Darolutamide). www.urologytimes.com/view/nccn-aw...
NCCN awards funding to 4 advanced prostate cancer research projects
The research projects are assessing combination therapies in advanced prostate cancer that include the use of relugolix.
www.urologytimes.com
November 27, 2024 at 10:13 PM
Thank you to NCCN, Sumitomo Pharma, Pfizer Oncology, and Bayer Oncology for supporting CLEARED (Comeback from Long CoursE ADT with RElugolix and Darolutamide). www.urologytimes.com/view/nccn-aw...
Now activated! CLEARED will enroll pts with high-risk localized, lymph node-positive or low volume HSPC (planned for treatment interruption) to receive 2 years of relugolix+darolutamide for PK studies of the combo and to assess T recovery after completion. clinicaltrials.gov/study/NCT064...
ClinicalTrials.gov
clinicaltrials.gov
November 27, 2024 at 10:10 PM
Now activated! CLEARED will enroll pts with high-risk localized, lymph node-positive or low volume HSPC (planned for treatment interruption) to receive 2 years of relugolix+darolutamide for PK studies of the combo and to assess T recovery after completion. clinicaltrials.gov/study/NCT064...
It's not too late to join our contribute to our team at movember.com/t/bellissimo to support Movember's efforts towards prostate cancer, testicular cancer and mental health research and resources.
BellissiMo's Mo Space
Movember, the month formerly known as November, is a moustache growing charity event held during November each year that raises funds and awareness for men's health.
https://movember.com/t/bellissimo?m…
November 24, 2024 at 12:53 PM
It's not too late to join our contribute to our team at movember.com/t/bellissimo to support Movember's efforts towards prostate cancer, testicular cancer and mental health research and resources.
See you at Kings Back Bay on Monday 11/25/24 from 6-10 pm for BellissiMO’s Movember Fundraising Finale. There will be food, karaoke, and celebration!
November 24, 2024 at 12:52 PM
See you at Kings Back Bay on Monday 11/25/24 from 6-10 pm for BellissiMO’s Movember Fundraising Finale. There will be food, karaoke, and celebration!
On multivariable analysis, duration of treatment >=12 months was independently associated with cPFS after T recovery, provocatively suggesting that prolonged systemic therapy could sterilize (or render permanently dormant) micrometastatic disease and lead to "cure" in a subset.
November 24, 2024 at 12:30 PM
On multivariable analysis, duration of treatment >=12 months was independently associated with cPFS after T recovery, provocatively suggesting that prolonged systemic therapy could sterilize (or render permanently dormant) micrometastatic disease and lead to "cure" in a subset.
Of note, 3-year cPFS after T recovery for patients receiving "total therapy" was 51% for those who received >=12 mo ADT, and the swimmer's plot shows patients out to > 10 years after T recovery.
November 24, 2024 at 12:30 PM
Of note, 3-year cPFS after T recovery for patients receiving "total therapy" was 51% for those who received >=12 mo ADT, and the swimmer's plot shows patients out to > 10 years after T recovery.
Can oligometastatic prostate cancer be cured with "total therapy" including radiation to all sites of disease and hormonal therapy? Dr. Praful Ravi and I along with colleagues at Dana-Farber present data from our cohort. www.sciencedirect.com/science/arti...
Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer
It is unclear whether “total therapy” (androgen deprivation therapy [ADT] with or without an androgen receptor pathway inhibitor [ARPI], metastasis-di…
www.sciencedirect.com
November 24, 2024 at 12:29 PM
Can oligometastatic prostate cancer be cured with "total therapy" including radiation to all sites of disease and hormonal therapy? Dr. Praful Ravi and I along with colleagues at Dana-Farber present data from our cohort. www.sciencedirect.com/science/arti...